TrialJournal of cancer research and clinical oncology2021

Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort.

S Thijssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.